Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. The Wisconsin epidemiologic study of diabetic retinopathy. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Clinical arrangement of classification of diabetic retinopathy. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Global Diabetic Retinopathy Project Group. Wilkinson CP, Ferris 3rd FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT. A modification of the Airlie House classification of diabetic retinopathy (DRS report no. The Diabetic Retinopathy Study Research Group. Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. Angiotensin II, VEGF and diabetic retinopathy. In: Wormald R, Smeeth L, Henshaw K, editors. Medical interventions for diabetic retinopathy. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. 2002 25:90–3.īoyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, Thompson TJ.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |